PCI-PAL (PCIP) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
8 Jul, 2026Executive summary
Achieved record new business sales and strong operational performance in the half-year, with significant progress on the product roadmap and successful resolution of a major patent case.
Revenue grew 26% year-over-year to £10.57m for H1 FY25, with recurring revenues at 91% of total.
Transitioned to profitability, entering a new growth phase with a focus on expanding the platform and product offerings.
Maintains a robust partner ecosystem, with over 700 customers and a strong presence in the UK and North America.
Record new business sales with ACV up 19% to £1.91m; strong partner ecosystem contributed 75% of new customers.
Financial highlights
Revenue increased 26% year-over-year, with underlying normalized growth at 13% due to prior period revenue deferral.
Annual Recurring Revenue (ARR) grew 21% to £16.8 million; Total Annual Contract Value (TACV) up 16% to £20.3 million.
Achieved group profitability with profit before tax of £175,000 and gross profit margin of 89.6%.
Gross margin improved to 90% from 89% year-over-year.
Cash balance of £4 million at period end, with access to an undrawn £3 million HSBC facility.
Outlook and guidance
Strong start to the second half with continued new business sales momentum and a growing 12-month pipeline.
Focus remains on driving deployments and revenue recognition to meet ARR and top-line targets while maintaining profitability.
Plans to expand internationally, launch new products, and consider selective M&A to complement organic growth.
Ongoing three-year plan refresh, with directional guidance provided in the interim update.
Board remains confident in delivering near-term objectives and scaling over the next 3-5 years.
Latest events from PCI-PAL
- Record ARR growth and strong partner sales drive positive outlook despite lower EBITDA.PCIP
H1 20262 May 2026 - Achieved 25% revenue growth, high retention, and strong partner-driven expansion.PCIP
H2 20253 Feb 2026 - ARR up 21% to £20.3m and revenue up 7%, with strong retention and US healthcare growth.PCIP
H1 2026 TU3 Feb 2026 - ARR up 25%, new AI product, and strong partnerships drive double-digit growth targets.PCIP
Trading Update8 Jan 2026 - Transforming into a secure engagement platform with strong growth, targeting GBP 50m revenue.PCIP
CMD 20253 Dec 2025 - 20% revenue growth, first adjusted EBITDA profit, and strong cash flow mark a pivotal year.PCIP
H2 202413 Jun 2025 - Revenue up 20% and new partnerships set the stage for further growth in FY25.PCIP
Trading Update13 Jun 2025 - Record H1 new business and 21% ARR growth highlight PCI Pal's strong momentum.PCIP
Trading Update6 Jun 2025